• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
President Donald Trump answers questions after autism announcement on September 22
Favicon Fierce Healthcare

Trump signs executive order to revise childhood vaccine schedule

The executive order recommends immunizing children against 11 diseases, rather than the 17 that are currently recommended by the CDC.
Heather Landi Aug 10, 2026 6:00pm
valentines day fail

Unapproved in US for decades, levosimendan stumbles in ph. 3

Aug 10, 2026 4:40pm
Gabriela Spanic in an Abbott ad for Cologuard Plus

Abbott taps telenovela star to take the drama out of cancer test

Aug 10, 2026 1:47pm
Graphic image of a red thumbs down against a blue background

ITM cancer drug spurned by FDA over manufacturing qualms

Aug 10, 2026 11:25am
Bristol Myers Squibb BMS Houston BMS

BMS unveils $2.3B outlay for manufacturing campus in Houston

Aug 10, 2026 11:13am
scissor cutting rope

Novo’s Catalent plant ditched in FDA refiling of SMA drug

Aug 10, 2026 10:06am
More News

Inizio Engage launches Connected Insights

Aug 9, 2026 1:00pm

Eli Lilly's Zepbound preferred by physicians: Spherix survey

Aug 7, 2026 11:36am

The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts

Aug 7, 2026 10:45am

Regulatory tracker: TransThera scores key cancer nod in China

Aug 7, 2026 10:45am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings